Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/VAXART-INC-40834288/news/Vaxart-verabreicht-ersten-Probanden-in-Phase-1-Studie-seines-Norovirus-Impfstoffkandidaten-bei-still-45224931/?utm_source=whatsapp&utm_medium=social&utm_campaign=share